Open resection of hypothalamic hamartomas for intractable epilepsy revisited, using intraoperative MRI
Hypothalamic hamartomas (HHs) are rare non-neoplastic lesions which cause drug-resistant epilepsy with associated behavioural, psychiatric and endocrine issues. With the development of new minimally invasive techniques for the treatment of HH, there is a need to reappraise the effectiveness and safety of each approach. We review the outcomes of HH patients treated surgically, utilizing intraoperative magnetic resonance imaging (IOMRI), by a team of Alder Hey NHS Foundation Trust tumour and epilepsy neurosurgeons since 2011.
Patient records of all HH cases operated on since 2011 were reviewed to confirm history of presentation and clinical outcomes.
Ten patients have undergone surgery for HH under the dual care of Alder Hey tumour and epilepsy neurosurgeons during this period. Eight cases had a midline transcallosal, interforniceal approach with the remaining 2 having a transcallosal, transforaminal approach. All patients had an IOMRI scan, with 40% needing further tumour resection post-IOMRI. Forty percent had a total resection, 3 patients had near-total resection and 3 patients had subtotal resection (~ 30% tumour residual on post-operative MRI). No new neurological complications developed post-operatively. Hypothalamic axis derangements were seen in 3 cases, including 1 diabetes insipidus with hypocortisolaemia, 1 hypodipsia and 1 transient hyperphagia. Eighty percent are seizure free; the remaining two patients have had significant improvements in seizure frequency.
IOMR was used to tailor the ideal tumour resection volume safely based on anatomy of the lesion, which combined with the open transcallosal, interforniceal route performed by surgeons experienced in the approach resulted in excellent, safe and effective seizure control.
KeywordsHypothalamic hamartoma Paediatric Neurosurgery Epilepsy
Compliance with ethical standards
Conflict of interest
The authors ceftify that they have no affiliations with or involvement in any organization or entitiy with any financial interest (such as honoria;educational grants;participation in speakers' bureaus;membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patientlicensing arrangments), or non financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
- 13.Procaccini E, Dorfmuller G, Fohlen M, Bulteau C, Delalande O (2006) Surgical Management of Hypothalamic Hamartomas with Epilepsy: the Stereoendoscopic Approach. Oper Neurosurg 59(suppl_4):ONS-336–ONS-346, https://doiorg.liverpool.idm.oclc.org/10.1227/01.NEU.0000233900.06146.72
- 18.Kubben PL, van Santbrink H, ter Laak-Poort M, Weber JW, Vles JSH, Granzen B, van Overbeeke JJ, Cornips EMJ (2012) Implementation of a mobile 0.15-T intraoperative MR system in pediatric neuro-oncological surgery: feasibility and correlation with early postoperative high-field strength MRI. Childs Nerv Syst 28(8):1171–1180CrossRefPubMedPubMedCentralGoogle Scholar